This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Centre Leon Berard, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
1 out of 39 
1 out of 1,853 
Years Active: 2025
Title: Patrick Dallemagne: Innovator in Cancer Treatment
Introduction
Patrick Dallemagne is a notable inventor based in Seulline, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Dallemagne's work focuses on enhancing the efficacy of anti-cancer agents.
Latest Patents
Dallemagne's latest patents include groundbreaking inventions such as "Carbazole derivatives sensitizing cells to anti-cancer agents." This invention concerns a compound of formula (I), which includes various groups that can be selected from hydrogen atoms, halogen atoms, alkyl groups, acyl groups, and more. Another significant patent is "Mitochondrial activity inhibitors targeting tumoral metabolism." This invention relates to compounds that target tumoral metabolism, providing potential new avenues for cancer treatment.
Career Highlights
Throughout his career, Patrick Dallemagne has worked with esteemed institutions such as the Centre Léon Bérard and the Centre National de la Recherche Scientifique (CNRS). His work in these organizations has allowed him to contribute to vital research in cancer therapies.
Collaborations
Dallemagne has collaborated with notable colleagues, including Renaud Prudent and Peggy Suzanne. These partnerships have further enriched his research and development efforts in the field of oncology.
Conclusion
Patrick Dallemagne's innovative work and patents in cancer treatment highlight his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile